Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes
Abstract Exploring the molecular basis of disease severity in rare disease scenarios is a challenging task provided the limitations on data availability. Causative genes have been described for Congenital Myasthenic Syndromes (CMS), a group of diverse minority neuromuscular junction (NMJ) disorders;...
Main Authors: | Iker Núñez-Carpintero, Maria Rigau, Mattia Bosio, Emily O’Connor, Sally Spendiff, Yoshiteru Azuma, Ana Topf, Rachel Thompson, Peter A. C. ’t Hoen, Teodora Chamova, Ivailo Tournev, Velina Guergueltcheva, Steven Laurie, Sergi Beltran, Salvador Capella-Gutiérrez, Davide Cirillo, Hanns Lochmüller, Alfonso Valencia |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-45099-0 |
Similar Items
-
Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
by: Kaela O’Connor, et al.
Published: (2023-05-01) -
Натриеви каналопатии
by: Stanislava Blagoeva, et al.
Published: (2023-09-01) -
Фенотип-генотип корелации при пациенти с вродена миотония тип Бекер
by: Stanislava Blagoeva, et al.
Published: (2023-09-01) -
Миопатия на Bethlem
by: Stanislava Blagoeva, et al.
Published: (2023-09-01) -
Хлорни каналопатии
by: Stanislava Blagoeva, et al.
Published: (2023-09-01)